샘플 요청 목록

 카트 문의
시장보고서
상품코드
2112284

창상관리 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 구입 형태별, 유통 채널별, 지역별 및 부문별 예측(2026-2033년)

Wound Care Market Size, Share & Trends Analysis Report By Product (Advanced Wound Dressing, Surgical Wound Care), By Application (Chronic, Acute), By End Use, By Mode Of Purchase, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 140 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ￦ 8,380,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ￦ 9,789,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ￦ 12,606,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

상처 관리 시장 요약

세계의 창상관리 시장 규모는 2025년에 251억 달러로 평가되며, 2026년 261억 달러에서 2033년까지 351억 달러로 확대하며, 2026-2033년의 연평균 성장률(CAGR)은 4.33%에 달할 것으로 예측됩니다.

북미가 시장을 주도하고 있으며, 2025년에는 46.9%라는 최대 점유율을 차지했습니다. 상처 관리 산업의 성장은 주로 당뇨병성 족부 궤양, 욕창, 정맥성 하지 궤양 등 만성 상처의 유병률 상승과 더불어, 상처 치유 장애가 발생하기 쉬운 고령 인구 증가에 의해 주도되고 있습니다.

또한 외과수술 건수의 증가, 외상 및 화상 사례 수의 증가, 첨단 상처 관리 제품의 채택 확대, 그리고 치유 촉진 및 임상 성과 향상을 통한 의료비 절감에 대한 중요성 인식이 높아짐에 따라 시장 성장이 지속적으로 지원되고 있습니다.

당뇨병성 족부 궤양, 욕창, 정맥성 하지 궤양, 동맥성 궤양 등 만성 상처의 유병률 증가는 상처 관리 시장의 주요 촉진요인으로 작용하고 있습니다. 당뇨병, 비만, 혈관 질환 및 고령화로 인한 부담이 증가함에 따라 장기적인 상처 관리와 첨단 치료 솔루션이 필요한 환자 수가 증가하고 있습니다. 이에 따라 치유 성과 향상, 합병증 완화, 의료비 절감을 목표로 한 첨단 상처 피복재, 음압 상처 치료(NPWT), 바이오의약품 및 디지털 상처 모니터링 기술의 도입이 가속화되고 있습니다.

자주 묻는 질문

  • 상처 관리 시장 규모는 어떻게 예측되나요?
  • 상처 관리 시장의 주요 성장 요인은 무엇인가요?
  • 상처 관리 시장에서 외과수술 건수의 증가는 어떤 영향을 미치나요?
  • 상처 관리 시장에서 첨단 치료 솔루션의 필요성은 어떻게 증가하고 있나요?
  • 상처 관리 시장에서 주요 기업은 어디인가요?

목차

제1장 조사 방법과 범위

제2장 개요

제3장 창상관리 시장 : 변수, 동향, 범위

제4장 창상관리 시장 : 제품별 추정·동향 분석

제5장 창상관리 시장 : 용도별 추정·동향 분석

제6장 창상관리 기기 시장 : 최종 용도별 추정·동향 분석

제7장 창상관리 시장 : 구입 방법별 추정·동향 분석

제8장 창상관리 시장 : 유통 채널별 추정·동향 분석

제9장 창상관리 시장 : 지역별 추정·동향 분석

제10장 경쟁 구도

KSA 26.08.19

Wound Care Market Summary

The global wound care market size was valued at USD 25.1 billion in 2025 and is projected to grow from USD 26.1 billion in 2026 to USD 35.1 billion by 2033, at a CAGR of 4.33% from 2026 to 2033. North America dominated the market, accounting for the largest share of 46.9% in 2025. The wound care industry's growth is primarily driven by the rising prevalence of chronic wounds, including diabetic foot ulcers, pressure injuries, and venous leg ulcers, as well as a growing aging population that is more susceptible to impaired wound healing.

In addition, increasing surgical procedures, trauma and burn cases, the expanding adoption of advanced wound care products, and greater emphasis on reducing healthcare costs through faster healing and improved clinical outcomes continue to support market growth.

The rising prevalence of chronic wounds, including diabetic foot ulcers, pressure injuries, venous leg ulcers, and arterial ulcers, is a major driver of the wound care market. The increasing burden of diabetes, obesity, vascular diseases, and an aging population has led to a growing number of patients requiring prolonged wound management and advanced treatment solutions. This has accelerated the adoption of advanced wound dressings, negative-pressure wound therapy (NPWT), biologics, and digital wound-monitoring technologies to improve healing outcomes, reduce complications, and lower healthcare costs.

Global Wound Care Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global wound care market report based on product, application, end use, mode of purchase, distribution channel, and region:

  • Product Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Advanced Wound Dressing
    • Moist
    • Foam Dressings
    • Hydrocolloid Dressings
    • Film Dressings
    • Alginate Dressings
    • Hydrogel Dressings
    • Collagen Dressings
    • Other Advanced Dressings
    • Antimicrobial
    • Silver
    • Non-silver
    • Honey
    • Iodine
    • Chitosan
    • PHMB
    • Others
    • Active
    • Biomaterials
    • Skin-substitute
    • Growth Factors
  • Surgical Wound Care
    • Sutures & staples
    • Tissue adhesive and sealants
    • Anti-infective dressing
  • Traditional Wound Care
    • Medical Tapes
    • Cotton
    • Bandages
    • Gauzes
    • Sponges
    • Cleansing Agents
  • Wound Therapy Devices
    • Negative pressure wound therapy
    • Oxygen and hyperbaric oxygen equipment
    • Electric stimulation devices
    • Pressure relief devices
    • Others
  • Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Chronic Wounds
    • Diabetic foot ulcers
    • Pressure ulcers
    • Stage 1
    • Stage 2
    • Stage 3
    • Stage 4
    • Deep tissue injury
    • Venous leg ulcers
    • Other chronic wounds
  • Acute Wounds
    • Surgical & traumatic wounds
    • Burns
    • 1st degree burns
    • 2nd degree burns
    • 3rd degree burns
  • End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Physician's Office
  • Nursing Homes
  • Others
  • Mode of Purchase Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Prescribed
  • Non-prescribed (OTC)
  • Distribution Channel Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Institutional Sales
  • Retail Sales
  • Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Wound Care Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
      • 3.2.1.2. Rising incidence of burn injuries
      • 3.2.1.3. Introduction of innovative and advanced wound products
      • 3.2.1.4. Rising geriatric population
      • 3.2.1.5. Increasing number of road accidents and trauma injuries
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced wound care products and chronic wound treatments
      • 3.2.2.2. Delayed diagnosis and lower treatment rates in emerging nations
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Improvements in public and private hospital infrastructure
      • 3.2.3.2. Growth potential in emerging economies in the wound care market
      • 3.2.3.3. Rising number of clinical trials
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Growing number of product recalls
      • 3.2.4.2. Lack of awareness about proper wound care practices and available treatment options
  • 3.3. Wound Care Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Wound Care Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Wound Care Market Movement Analysis
  • 4.3. Global Wound Care Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million/Billion)
  • 4.4. Advanced Wound Dressing
    • 4.4.1. Advanced Wound Dressing market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 4.4.2. Moist
      • 4.4.2.1. Moist market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 4.4.2.2. Foam Dressing
        • 4.4.2.2.1. Foam Dressing market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 4.4.2.3. Hydrocolloid Dressings
        • 4.4.2.3.1. Hydrocolloid dressings market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 4.4.2.4. Film Dressings
        • 4.4.2.4.1. Film dressings market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 4.4.2.5. Alginate Dressings
        • 4.4.2.5.1. Alginate dressings market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 4.4.2.6. Hydrogel Dressings
        • 4.4.2.6.1. Hydrogel dressings market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 4.4.2.7. Collagen Dressings
        • 4.4.2.7.1. Collagen dressings market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 4.4.2.8. Other Advanced Dressings
        • 4.4.2.8.1. Other advanced dressings market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 4.4.3. Antimicrobial
      • 4.4.3.1. Antimicrobial market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 4.4.3.2. Silver
        • 4.4.3.2.1. Silver market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 4.4.3.3. Non-silver
        • 4.4.3.3.1. Non-silver market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
        • 4.4.3.3.2. Honey
          • 4.4.3.3.2.1. Honey market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
        • 4.4.3.3.3. Iodine
          • 4.4.3.3.3.1. Iodine market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
        • 4.4.3.3.4. Chitosan
          • 4.4.3.3.4.1. Chitosan market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
        • 4.4.3.3.5. PHMB
          • 4.4.3.3.5.1. PHMB market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
        • 4.4.3.3.6. Others
          • 4.4.3.3.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 4.4.4. Active
      • 4.4.4.1. Active market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 4.4.4.2. Biomaterials
        • 4.4.4.2.1. Biomaterials market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 4.4.4.3. Skin-substitute
        • 4.4.4.3.1. Skin-substitute market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 4.4.4.4. Growth Factors
        • 4.4.4.4.1. Growth factors market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 4.5. Surgical wound care
    • 4.5.1. Surgical wound care market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.5.2. Sutures & staples
      • 4.5.2.1. Sutures & staples market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.5.3. Tissue adhesives & sealants
      • 4.5.3.1. Tissue adhesives & sealants market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.5.4. Anti-infective dressing
      • 4.5.4.1. Anti-infective dressing market estimates and forecast, 2021 - 2033 (USD Million/Billion)
  • 4.6. Traditional wound care
    • 4.6.1. Traditional wound care market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.6.2. Medical tapes
      • 4.6.2.1. Medical tapes market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.6.3. Cotton
      • 4.6.3.1. Cotton market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.6.4. Bandages
      • 4.6.4.1. Bandages market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.6.5. Gauzes
      • 4.6.5.1. Gauzes market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.6.6. Sponges
      • 4.6.6.1. Sponges market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.6.7. Cleansing agents
      • 4.6.7.1. Cleansing agents market estimates and forecast, 2021 - 2033 (USD Million/Billion)
  • 4.7. Wound therapy devices
    • 4.7.1. Wound therapy devices market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.7.2. Negative pressure wound therapy
      • 4.7.2.1. Negative pressure wound therapy market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.7.3. Oxygen and hyperbaric oxygen equipment
      • 4.7.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.7.4. Electric stimulation devices
      • 4.7.4.1. Electric stimulation devices market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.7.5. Pressure relief devices
      • 4.7.5.1. Pressure relief devices market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 4.7.6. Others
      • 4.7.6.1. Others market estimates and forecast, 2021 - 2033 (USD Million/Billion)

Chapter 5. Wound Care Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Wound Care Market Movement Analysis
  • 5.3. Global Wound Care Market Size & Trend Analysis, by Application, 2021 - 2033 (USD Million/Billion)
  • 5.4. Acute Wounds
    • 5.4.1. Acute wounds market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 5.4.2. Surgical & traumatic wounds
      • 5.4.2.1. Surgical & traumatic wounds market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 5.4.3. Burns
      • 5.4.3.1. Burns market estimates and forecast, 2021 - 2033 (USD Million/Billion)
      • 5.4.3.2. 1st degree burns
        • 5.4.3.2.1. 1st degree burns market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 5.4.3.3. 2nd degree burns
        • 5.4.3.3.1. 2nd degree burns market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 5.4.3.4. 3rd degree burns
        • 5.4.3.4.1. 3rd degree burns market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 5.5. Chronic Wounds
    • 5.5.1. Chronic wounds market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 5.5.2. Diabetic foot ulcers
      • 5.5.2.1. Diabetic foot ulcers market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 5.5.3. Pressure ulcers
      • 5.5.3.1. Pressure ulcers market estimates and forecast, 2021 - 2033 (USD Million/Billion)
      • 5.5.3.2. Stage 1
        • 5.5.3.2.1. Stage 1 market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 5.5.3.3. Stage 2
        • 5.5.3.3.1. Stage 2 market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 5.5.3.4. Stage 3
        • 5.5.3.4.1. Stage 3 market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 5.5.3.5. Stage 4
        • 5.5.3.5.1. Stage 4 market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
      • 5.5.3.6. Deep Tissue Injury
        • 5.5.3.6.1. Deep tissue injury market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 5.5.4. Venous leg ulcers
      • 5.5.4.1. Venous leg ulcers market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 5.5.5. Others chronic wounds
      • 5.5.5.1. Others chronic wounds market estimates and forecast, 2021 - 2033 (USD Million/Billion)

Chapter 6. Wound Care Devices: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Wound Care Market Movement Analysis
  • 6.3. Global Wound Care Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million/Billion)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecast, 2021 - 2033 (USD Million/Billion)
  • 6.5. Specialty clinics
    • 6.5.1. Specialty clinics centers market estimates and forecast, 2021 - 2033 (USD Million/Billion)
  • 6.6. Home healthcare
    • 6.6.1. Home healthcare market estimates and forecast, 2021 - 2033 (USD Million/Billion)
  • 6.7. Physician's office
    • 6.7.1. Physician's office market estimates and forecast, 2021 - 2033 (USD Million/Billion)
  • 6.8. Nursing Homes
    • 6.8.1. Nursing homes market estimates and forecast, 2021 - 2033 (USD Million/Billion)
  • 6.9. Others
    • 6.9.1. Others market estimates and forecast, 2021 - 2033 (USD Million/Billion)

Chapter 7. Wound Care Market: Mode of Purchase Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Wound Care Market Movement Analysis
  • 7.3. Global Wound Care Market Size & Trend Analysis, by Mode Of Purchase, 2021 - 2033 (USD Million/Billion)
  • 7.4. Prescribed
    • 7.4.1. Prescribed market estimates and forecast, 2021 - 2033 (USD Million/Billion)
  • 7.5. Non-prescribed (OTC)
    • 7.5.1. Non-prescribed (OTC) market estimates and forecast, 2021 - 2033 (USD Million/Billion)

Chapter 8. Wound Care Market: Distribution Channel Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Wound Care Market Movement Analysis
  • 8.3. Global Wound Care Market Size & Trend Analysis, by Distribution Channel, 2021 - 2033 (USD Million/Billion)
  • 8.4. Institutional sales
    • 8.4.1. Institutional sales market estimates and forecast, 2021 - 2033 (USD Million/Billion)
  • 8.5. Retail sales
    • 8.5.1. Retail sales market estimates and forecast, 2021 - 2033 (USD Million/Billion)

Chapter 9. Wound Care Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2021 - 2033
  • 9.3. North America
    • 9.3.1. Market estimates and forecast, 2021 - 2033 (USD Million/Billion)
    • 9.3.2. U.S.
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Competitive scenario
      • 9.3.2.3. Regulatory framework
      • 9.3.2.4. Reimbursement scenario
      • 9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.3.3. Canada
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Competitive scenario
      • 9.3.3.3. Regulatory framework
      • 9.3.3.4. Reimbursement scenario
      • 9.3.3.5. Canada market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.3.4. Mexico
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Competitive scenario
      • 9.3.4.3. Regulatory framework
      • 9.3.4.4. Reimbursement scenario
      • 9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Competitive scenario
      • 9.4.1.3. Regulatory framework
      • 9.4.1.4. Reimbursement scenario
      • 9.4.1.5. UK market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Regulatory framework
      • 9.4.2.4. Reimbursement scenario
      • 9.4.2.5. Germany market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. Regulatory framework
      • 9.4.3.4. Reimbursement scenario
      • 9.4.3.5. France market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. Regulatory framework
      • 9.4.4.4. Reimbursement scenario
      • 9.4.4.5. Italy market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Competitive scenario
      • 9.4.5.3. Regulatory framework
      • 9.4.5.4. Reimbursement scenario
      • 9.4.5.5. Spain market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.4.6. Denmark
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Competitive scenario
      • 9.4.6.3. Regulatory framework
      • 9.4.6.4. Reimbursement scenario
      • 9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Competitive scenario
      • 9.4.7.3. Regulatory framework
      • 9.4.7.4. Reimbursement scenario
      • 9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.4.8. Norway
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Competitive scenario
      • 9.4.8.3. Regulatory framework
      • 9.4.8.4. Reimbursement scenario
      • 9.4.8.5. Norway market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Competitive scenario
      • 9.5.1.3. Regulatory framework
      • 9.5.1.4. Reimbursement scenario
      • 9.5.1.5. Japan market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.5.2. India
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. Reimbursement scenario
      • 9.5.2.5. India market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.5.3. China
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. Reimbursement scenario
      • 9.5.3.5. China market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.5.4. South Korea
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. Reimbursement scenario
      • 9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.5.5. Australia
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Competitive scenario
      • 9.5.5.3. Regulatory framework
      • 9.5.5.4. Reimbursement scenario
      • 9.5.5.5. Australia market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Competitive scenario
      • 9.5.6.3. Regulatory framework
      • 9.5.6.4. Reimbursement scenario
      • 9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Competitive scenario
      • 9.6.1.3. Regulatory framework
      • 9.6.1.4. Reimbursement scenario
      • 9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. Reimbursement scenario
      • 9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Competitive scenario
      • 9.7.1.3. Regulatory framework
      • 9.7.1.4. Reimbursement scenario
      • 9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. Reimbursement scenario
      • 9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. Reimbursement scenario
      • 9.7.3.5. UAE market estimates and forecasts, 2021 - 2033 (USD Million/Billion)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Competitive scenario
      • 9.7.4.3. Regulatory framework
      • 9.7.4.4. Reimbursement scenario
      • 9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Key Company Profiles
    • 10.2.1. Smith+Nephew
      • 10.2.1.1. Company overview
      • 10.2.1.2. Financial performance
      • 10.2.1.3. Product benchmarking
      • 10.2.1.4. Strategic initiatives
    • 10.2.2. Convatec Group PLC
      • 10.2.2.1. Company overview
      • 10.2.2.2. Financial performance
      • 10.2.2.3. Product benchmarking
      • 10.2.2.4. Strategic initiatives
    • 10.2.3. Molnlycke Health Care AB
      • 10.2.3.1. Company overview
      • 10.2.3.2. Financial performance
      • 10.2.3.3. Product benchmarking
      • 10.2.3.4. Strategic initiatives
    • 10.2.4. Baxter
      • 10.2.4.1. Company overview
      • 10.2.4.2. Financial performance
      • 10.2.4.3. Product benchmarking
      • 10.2.4.4. Strategic initiatives
    • 10.2.5. DeRoyal Industries, Inc.
      • 10.2.5.1. Company overview
      • 10.2.5.2. Financial performance
      • 10.2.5.3. Product benchmarking
      • 10.2.5.4. Strategic initiatives
    • 10.2.6. Coloplast Corp.
      • 10.2.6.1. Company overview
      • 10.2.6.2. Financial performance
      • 10.2.6.3. Product benchmarking
      • 10.2.6.4. Strategic initiatives
    • 10.2.7. Medtronic
      • 10.2.7.1. Company overview
      • 10.2.7.2. Financial performance
      • 10.2.7.3. Product benchmarking
      • 10.2.7.4. Strategic initiatives
    • 10.2.8. 3M
      • 10.2.8.1. Company overview
      • 10.2.8.2. Financial performance
      • 10.2.8.3. Product benchmarking
      • 10.2.8.4. Strategic initiatives
    • 10.2.9. INTEGRA LIFESCIENCES
      • 10.2.9.1. Company overview
      • 10.2.9.2. Financial performance
      • 10.2.9.3. Product benchmarking
      • 10.2.9.4. Strategic initiatives
    • 10.2.10. Medline Industries, LP
      • 10.2.10.1. Company overview
      • 10.2.10.2. Financial performance
      • 10.2.10.3. Product benchmarking
      • 10.2.10.4. Strategic initiatives
    • 10.2.11. Johnson & Johnson Services, Inc.
      • 10.2.11.1. Company overview
      • 10.2.11.2. Financial performance
      • 10.2.11.3. Product benchmarking
      • 10.2.11.4. Strategic initiatives
    • 10.2.12. B. Braun SE
      • 10.2.12.1. Company overview
      • 10.2.12.2. Financial performance
      • 10.2.12.3. Product benchmarking
      • 10.2.12.4. Strategic initiatives
    • 10.2.13. Cardinal Health
      • 10.2.13.1. Company overview
      • 10.2.13.2. Financial performance
      • 10.2.13.3. Product benchmarking
      • 10.2.13.4. Strategic initiatives
    • 10.2.14. Organogenesis Inc.
      • 10.2.14.1. Company overview
      • 10.2.14.2. Financial performance
      • 10.2.14.3. Product benchmarking
      • 10.2.14.4. Strategic initiatives
    • 10.2.15. MIMEDX Group, Inc.
      • 10.2.15.1. Company overview
      • 10.2.15.2. Financial performance
      • 10.2.15.3. Product benchmarking
      • 10.2.15.4. Strategic initiatives
    • 10.2.16. Advanced Medical Solutions Group plc
      • 10.2.16.1. Company overview
      • 10.2.16.2. Financial performance
      • 10.2.16.3. Product benchmarking
      • 10.2.16.4. Strategic initiatives
    • 10.2.17. Plastod SpA
      • 10.2.17.1. Company overview
      • 10.2.17.2. Financial performance
      • 10.2.17.3. Product benchmarking
      • 10.2.17.4. Strategic initiatives
    • 10.2.18. AVERY DENNISON CORPORATION
      • 10.2.18.1. Company overview
      • 10.2.18.2. Financial performance
      • 10.2.18.3. Product benchmarking
      • 10.2.18.4. Strategic initiatives
    • 10.2.19. Lohmann Rauscher GmbH & Co. KG
      • 10.2.19.1. Company overview
      • 10.2.19.2. Financial performance
      • 10.2.19.3. Product benchmarking
      • 10.2.19.4. Strategic initiatives
    • 10.2.20. Nanordica Medical
      • 10.2.20.1. Company overview
      • 10.2.20.2. Financial performance
      • 10.2.20.3. Product benchmarking
      • 10.2.20.4. Strategic initiatives
    • 10.2.21. MBP - MEDICAL BIOMATERIAL PRODUCTS GmbH
      • 10.2.21.1. Company overview
      • 10.2.21.2. Financial performance
      • 10.2.21.3. Product benchmarking
      • 10.2.21.4. Strategic initiatives
    • 10.2.22. URGO MEDICAL
      • 10.2.22.1. Company overview
      • 10.2.22.2. Financial performance
      • 10.2.22.3. Product benchmarking
      • 10.2.22.4. Strategic initiatives
  • 10.3. Heat Map Analysis/ Company Market Position Analysis
  • 10.4. Estimated Company Market Share Analysis, 2024/2025
  • 10.5. List of Other Key Market Players
×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기